Posted by Michael Wonder on 18 Jul 2023
Outcome statement - June 2023 DUSC meeting
18 July 2023 - The outcome statement from the June 2023 DUSC meeting is now available.
The DUSC reviewed the utilisation of the following PBS listed medicines in June 2023:
- Olaparib - ovarian cancer
- Omalizumab - urticaria
